SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-17-000039
Filing Date
2017-10-03
Accepted
2017-10-03 08:00:41
Documents
3
Period of Report
2017-10-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FOR PROJECT RAVEN form8-kpressrelease07252017.htm 8-K 31241
2 exhibit2.htm EX-2 515759
3 exhibit99.htm EX-99 22778
  Complete submission text file 0001367644-17-000039.txt   570949
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 171116104
SIC: 2834 Pharmaceutical Preparations